Expressions of ERs, including ERα, ERβ, and GPER, as well as aromatase, which is an estrogen synthase, have been reported in NSCLC tissue, including men and postmenopausal women, and have been associated with the NSCLC prognosis [40,41,42,43]. This evidence concerns the gene CYP19A1 and non-small cell lung carcinoma.